%0 Journal Article %A Agustín Sabio Vera %T Discontinuity of the deadly infection rate for the COVID-19 pandemia due to lockdown measures %D 2020 %R 10.1101/2020.08.05.20168880 %J medRxiv %P 2020.08.05.20168880 %X An asymmetric version of the classical Kermack-McKendrick description of an epidemic evolution is presented in terms of four independent parameters. This is enough to obtain an accurate description of the different stages of the COVID-19 pandemia in any country for the reported daily and total number of casualties due to the infection. The asymmetry accounts for lockdown effects introduced to reduce the impact of the epidemic outburst. A set of new variables allows for an analytic study of the evolution of the system before and after the lockdown measures are put in place. A continuous matching is possible for all variables in the system apart from the time dependence of the infection rate. An analytic expression is obtained for this discontinuity which is proposed as a good quantity to gauge the efficiency of the lockdown measures. A study of this variable for different countries is performed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has been supported by the Spanish Research Agency (Agencia Estatal de Investigacion) through the grant IFT Centro de Excelencia Severo Ochoa SEV-2016-0597, and the Spanish Government grants FPA2015-65480-P, FPA2016-78022-P.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Universidad Autonoma de MadridAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe public data considered here have been taken from "Daily New Deaths in Spain" in the real time world statistics generated by Worldometer at https://www.worldometers.info/coronavirus/country/spain/. The same source for officially reported deaths has been used in all the studies of this work.The public data provided by EuroMOMO, the European mortality monitoring activity https://www.euromomo.eu) have also been used. %U https://www.medrxiv.org/content/medrxiv/early/2020/08/06/2020.08.05.20168880.full.pdf